menu
    • menu

    Company profile for Laminar Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Laminar Pharmaceuticals S.A. (Laminar) is a Spanish biotechnological company established in 2006, dedicated to translational health research. The company focuses on the rational design and development of drugs for treating oncological and other pathologies. Laminar specializes in synthetic fatty acids considered "First-in-class Health Solutions" and employs a novel technology called Melitherapy (MLT or Membrane Lipid Therapy)....
    Laminar Pharmaceuticals S.A. (Laminar) is a Spanish biotechnological company established in 2006, dedicated to translational health research. The company focuses on the rational design and development of drugs for treating oncological and other pathologies. Laminar specializes in synthetic fatty acids considered "First-in-class Health Solutions" and employs a novel technology called Melitherapy (MLT or Membrane Lipid Therapy). The company oversees all processes, from designing molecules to conducting clinical trials, emphasizing continuous investment in research and development with high-quality standards.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Laminar PharmaSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Palma de Mallorca, Baleares
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://laminarpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/laminarpharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/LaminarPharma?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Laminar Pharma reveals open-label data for LAM561 in glioblastoma
    Laminar Pharma reveals open-label data for LAM561 in glioblastoma

    05 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/laminar-pharma-announces-first-open-label-progression-free-survival-data-for-lam561-in-combination-with-standard-of-care-in-first-line-therapy-for-newly-diagnosed-glioblastoma-mgmt-methylated-patients-302393021.html

    PR NEWSWIRE
    05 Mar 2025
    Share Share
    Laminar Completes CLINGLIO Glioblastoma Trial Recruitment
    Laminar Completes CLINGLIO Glioblastoma Trial Recruitment

    11 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/last-patient-in-laminar-pharmaceuticals-sa-completes-recruitment-for-clinglio-the-phase-2b3-clinical-trial-of-idroxioleic-acid-lam561-in-combination-with-rt-and-tmz-for-adults-with-newly-diagnosed-glioblastoma-302169673.html

    PR NEWSWIRE
    11 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search